AAAyla Solmaz Avcıkurt

Ayla Solmaz Avcıkurt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ayla Solmaz Avcıkurt has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fetuin-A Attenuates HMGB1/TLR4-Mediated Ovarian Ischemia/Reperfusion Injury

    by Ezgi Tolu Cenk, Selim Afşar, Özgür Bulmuş, Figen Efe Çamili, Mustafa Hilmi Yaranoğlu, Mine İslimye Taşkın, Ayla Solmaz Avcıkurt, Gürhan Güney, Merve Akış Yılmaz, Gülay Turan, et al.

    Background/Objectives: Adnexal torsion causes ovarian ischemia/reperfusion injury and may impair ovarian reserve. This study evaluated the protective effects of Fetuin-A in a rat torsion/detorsion model. Methods: Twenty-eight female Wistar rats were assigned to Sham, T/D, T/D+Fetuin-A treatment, and Fetuin-A pretreatment+T/D groups. Bilateral ovarian torsion was induced for 3 h followed by 2 h of detorsion/reperfusion, and Fetuin-A was administered intraperitoneally at 100 mg/kg. Serum cytokines and AMH, qRT-PCR markers, histopathological injury, and immunohistochemical expression of Fetuin-A, HIF-1α, GPx, and Bcl-2 were evaluated. Results: T/D induced a systemic inflammatory response, reduced AMH, increased HMGB1/TLR4-associated and cell-stress markers, and caused marked ovarian histopathological injury. Fetuin-A attenuated inflammatory and molecular stress responses, while pretreatment produced the most consistent protection, preserving AMH, reducing histopathological injury and HIF-1α immunoreactivity, and restoring GPx, Bcl-2, and Fetuin-A immunoreactivity. Exploratory STRING analysis identified functional enrichment related to oxidative stress, autophagy, apoptosis, and HIF-1 signaling, providing hypothesis-generating context without establishing causal pathway activity. Conclusions: These findings indicate that Fetuin-A administration, particularly before torsion, was associated with reduced inflammatory and tissue-stress responses during early ovarian ischemia/reperfusion injury. Further studies are needed to determine optimal dosing, clinically feasible timing, and long-term reproductive outcomes.

  • Open Access

    Intraperitoneal Fetuin-A Modulates HMGB1-Associated Inflammatory Remodeling in Experimental Endometriosis

    by Selim Afşar, Özgür Bulmuş, Figen Efe Çamili, Mustafa Hilmi Yaranoğlu, Mine İslimye Taşkın, Ayla Solmaz Avcıkurt, Gürhan Güney, Ezgi Tolu Cenk, Hilmi Bolat, Ceyda Sancaklı Usta, et al.

    Background/Objectives: Endometriosis is a chronic inflammatory disorder characterized by ectopic endometrial-like lesions, inflammatory activation, angiogenesis, and tissue remodeling. Fetuin-A has been implicated in inflammatory regulation; however, its effects on HMGB1 mRNA expression and lesion-remodeling markers in endometriosis remain unclear. This study investigated whether intraperitoneal Fetuin-A is associated with changes in systemic inflammation and lesion-associated remodeling in a surgically induced rat model of endometriosis. Methods: After confirmation of viable endometriotic implants, female Wistar albino rats received intraperitoneal Fetuin-A or saline. Serum IL-1β, IL-6, TNF-α, and AMH levels were measured. Endometriotic implants were evaluated by qRT-PCR for HMGB1 and OPN mRNA expression and by immunohistochemistry for Fetuin-A, p62/SQSTM1, caspase-3, VEGF, OPN, and SOD1. Results: For the primary lesion-area endpoint, Fetuin-A treatment remained associated with significantly lower post-treatment lesion area after adjustment for baseline lesion area. Compared with saline, Fetuin-A treatment significantly reduced serum IL-1β, IL-6, and TNF-α concentrations and was associated with lower AMH levels. In endometriotic implants, Fetuin-A was associated with marked downregulation of HMGB1 mRNA expression, whereas OPN mRNA was modestly increased. Immunohistochemistry showed increased Fetuin-A, p62/SQSTM1, caspase-3, and SOD1 staining, together with reduced VEGF and OPN staining after Fetuin-A treatment. Conclusions: Intraperitoneal Fetuin-A attenuated experimental endometriosis, with a significant baseline-adjusted reduction in the primary lesion-area endpoint, systemic inflammatory suppression, and reduced HMGB1 mRNA expression, accompanied by changes in angiogenesis-, oxidative stress-, apoptosis-, autophagy-, and remodeling-associated markers. Because HMGB1 protein/release, RAGE/TLR4/NF-κB signaling, and specific fibrosis markers were not assessed, these findings should not be interpreted as direct HMGB1 pathway inhibition or definitive anti-fibrotic activity. Overall, these results support further mechanistic studies evaluating Fetuin-A as a potential modulator of inflammatory and lesion-remodeling processes in endometriosis.

  • Open Access

    Comparison of Long Non-Coding RNA Expressions in Endometrial Polyp and Endometrial Cancer Cases

    by Cagla Bahar Bulbul, Ayla Solmaz Avcikurt, Cagla Kayabasi, Aysegul Dalmizrak, Zafer Erol

    Aim: This study compared the expression of four long non-coding RNAs (lncRNAs)—XIST, UCA1, MALAT1, and ANRIL—in endometrial polyps (EP), endometrial cancer (EC), and normal endometrium to assess their diagnostic and prognostic potential. Materials and Methods: In this prospective study, 150 women undergoing endometrial biopsy between August 2021 and April 2024 were included (50 EP, 50 EC, 50 controls). RNA was extracted from FFPE tissue, converted to cDNA, and analyzed using SYBR Green-based qRT-PCR with U6 snRNA as reference. Statistical analysis included ANOVA/Kruskal–Wallis, logistic regression, and ROC analysis; p < 0.05 and fold change ≥±2 were considered significant. Results: The mean age was significantly higher in EC than in EP and controls (p < 0.05), with BMI also elevated (p = 0.006). UCA1 expression was upregulated in EP compared with controls (p = 0.008) but markedly downregulated in EC (p < 0.0005). XIST, MALAT1, and ANRIL showed upward trends in EC without independent statistical significance. Logistic regression identified age and UCA1 as the only independent predictors. Diagnostic accuracy was high: EC vs. control AUC = 0.98; EP vs. control AUC = 0.86; EC vs. EP AUC = 0.87. Age predicted malignancy, while high UCA1 was associated with EP and low UCA1 with EC. Discussion: Age and UCA1 expression were the strongest discriminators between lesion types. UCA1’s dual, context-dependent role—promoting benign proliferation in EP and decreasing in EC—suggests potential biomarker utility. Other lncRNAs aligned with oncogenic functions but lacked independent predictive value. Combining molecular and clinical parameters could improve risk stratification and early detection, warranting validation in larger cohorts.